![Cytochroma Inc. logo](/globalassets/digizuite/25950-cytochroma-inc-logo-couleur.png?v=4aa9f6)
Exited company
Cytochroma Inc.
Lead
![Ela Borenstein - Vice president, venture capital at BDC](/globalassets/digizuite/12664-ela-borenstein-medium.jpg?v=4a484e)
About the company
Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).